Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NSE India Stock Exchange  >  Divi's Laboratories Limited    DIVISLAB   INE361B01024

DIVI'S LABORATORIES LIMITED

(DIVISLAB)
  Report
Delayed Quote. Delayed NSE India Stock Exchange - 10/23 07:14:09 am
3068.85 INR   -0.80%
08/10Sensex, Nifty settle higher on pharma boost
RE
05/22DIVI'S LABORATORIES LIMITED : annual earnings release
02/25DIVI'S LABORATORIES LIMITED : Ex-dividend day for interim dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Divi's Laboratories Ltd : Press Release Qtr 1 2013-14

share with twitter share with LinkedIn share with facebook
08/05/2013 | 04:20am EDT

DIVI'S LABORATORIES LIMITED Divi Towers, Dharam Karan Road Hyderabad 500 016

Phone: 23786300 email: Kishore@divislaboratories.com

PRESS RELEASE dated 03rd August, 2013

Divi's Labs earns a PAT of Rs. 175 crores for Q1 of FY14
Divi's Laboratories has earned a Profit after Tax (PAT) of Rs.175 crores on a total income of Rs. 517 crores for the 1st quarter of the year 2013-14 on a Standalone basis. PAT for the corresponding quarter of the last year was Rs.167 crores on a total income of Rs.470 crores.
Tax provision for the current quarter came to Rs.54 crores as against a tax provision of Rs.47 crores for the corresponding quarter of last year.
Forex gain for the current quarter amounted to Rs. 43 crores as against a gain of Rs. 30 crores during the corresponding quarter of the last year.

distributed by

share with twitter share with LinkedIn share with facebook
All news about DIVI'S LABORATORIES LIMITED
08/10Sensex, Nifty settle higher on pharma boost
RE
05/22DIVI'S LABORATORIES LIMITED : annual earnings release
02/25DIVI'S LABORATORIES LIMITED : Ex-dividend day for interim dividend
FA
2019DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2018DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2017DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2016DIVI'S LABORATORIES LTD : Ex-dividend day for interim dividend
FA
2015DIVI'S LABORATORIES LTD : BONUS ISSUE: 1 new share for 1 existing share
FA
2015DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
2014DIVI'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2021 65 733 M 890 M 890 M
Net income 2021 17 632 M 239 M 239 M
Net cash 2021 3 823 M 51,7 M 51,7 M
P/E ratio 2021 46,4x
Yield 2021 0,60%
Capitalization 815 B 11 036 M 11 028 M
EV / Sales 2021 12,3x
EV / Sales 2022 10,5x
Nbr of Employees -
Free-Float 47,6%
Chart DIVI'S LABORATORIES LIMITED
Duration : Period :
Divi's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIVI'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 3 257,15 INR
Last Close Price 3 068,85 INR
Spread / Highest target 22,7%
Spread / Average Target 6,14%
Spread / Lowest Target -12,0%
EPS Revisions
Managers
NameTitle
Kiran Satchandra Divi Chief Executive Officer & Executive Director
Ramesh B. V. Nimmagadda Non-Executive Chairman
L. Kishore Babu Chief Financial Officer
L. Ramesh Babu Chief Information Officer & VP-Procurement
Ramesh Babu M. General Manager-Technical Operations
Sector and Competitors